RT Journal Article
SR Electronic
T1 Cholera past and future in Nigeria: are the Global Task Force on Cholera Control’s 2030 targets achievable?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.12.06.22283154
DO 10.1101/2022.12.06.22283154
A1 Charnley, Gina E C
A1 Yennan, Sebastian
A1 Ochu, Chinwe
A1 Kelman, Ilan
A1 Gaythorpe, Katy A M
A1 Murray, Kris A
YR 2022
UL http://medrxiv.org/content/early/2022/12/07/2022.12.06.22283154.abstract
AB Background Understanding and continually assessing the achievability of global health targets is key to reducing disease burden and mortality. The Global Task Force on Cholera Control (GTFCC) Roadmap aims to reduce cholera deaths by 90% and eliminate the disease in twenty countries by 2030. The Roadmap has three axes focusing on reporting, response and coordination. Here, we assess the achievability of the GTFCC targets in Nigeria and identify where the three axes could be strengthened to reach and exceed these goals.Methodology/Principal Findings First, historical data were analysed for cholera death rates and a range of well-established cholera risk factors (particularly those included in the best fit models), using correlation, regression, autocorrelation function and AutoRegressive Integrated Moving Averages. Next, future scenario datasets were created (based on varying degrees of socioeconomic development and emission reductions) and used to project future cholera outbreak occurrence and transmission to 2070. The two models used were a generalised linear model and a random forest model. The historical data highlighted the significant cholera burden in Nigeria and its correlation with sanitation access. The projections suggest that significant reductions in cholera cases could be achieved by 2030, particularly in the more developed southern states, but increases in cases remain a possibility. Meeting the 2030 target, nationally, currently looks unachievable and we propose a new 2050 target focusing on reducing regional inequities.Conclusion/Significance The 2030 targets could potentially be reached by 2030 in some parts of Nigeria, but more effort is needed to reach these targets at a national level, particularly through access and incentives to cholera testing, sanitation expansion, poverty alleviation and urban planning. The results highlight the importance of and how modelling studies can be used to inform cholera policy and the potential for this to be applied in other contexts.Author Summary By statistically analysing the historical cholera deaths and risk factors data and using future scenario cholera forecasting, we assessed the achievability of the Global Task Force for Cholera Control 2030 Roadmap in Nigeria, based on sustainable development and environmental protection. The results highlighted how regional inequities within Nigeria will likely prevent the 2030 targets being reached. The northern states in Nigeria are more rural, less developed and have greater levels of insecurity and conflict. Reaching the levels of peace and development achieved in the south at a national level, along with improving urban planning and access and incentives to cholera testing, will be fundamental in reaching the Roadmap targets in Nigeria. Cholera forecasting is understudied and here we present the most in-depth projections available for Nigeria. Projections provide a snapshot of potential future conditions and show what is needed going forward to meet and exceed health targets and reduce disease burden. We highlight how quantitative research can be used to inform policy and the relevance of doing so. Quantitative research should fundamentally aim to improve global health and by presenting our work with a strong policy focus, we highlight the relevance and importance of doing so.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Natural Environmental Research Council [NE/S007415/1], as part of the Grantham Institute for Climate Change and the Environment's (Imperial College London) Science and Solutions for a Changing Planet Doctoral Training Partnership. We also acknowledge joint Centre funding from the UK Medical Research Council and Department for International Development [MR/R0156600/1].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The datasets and methods used here were approved by Imperial College Research Ethics Committee and a data sharing agreement between NCDC and the authors. Formal consent was not obtained for individuals in the data used here, as the data were anonymised.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe cholera data used in the analysis are available from the WHO Global Health Observatory and the Global Health Data Exchange, while subnational data were shared by NCDC and can be requested. Details of social and environmental data are available, including a list of sources, in Table 1.